nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP1A2—Carmustine—melanoma	0.138	0.27	CbGbCtD
Rifabutin—CYP1A2—Vemurafenib—melanoma	0.109	0.213	CbGbCtD
Rifabutin—CYP3A4—Temozolomide—melanoma	0.104	0.204	CbGbCtD
Rifabutin—CYP1A2—Dacarbazine—melanoma	0.0836	0.163	CbGbCtD
Rifabutin—CYP3A4—Vemurafenib—melanoma	0.0571	0.112	CbGbCtD
Rifabutin—CYP3A4—Docetaxel—melanoma	0.0196	0.0383	CbGbCtD
Rifabutin—HSP90B1—hair follicle—melanoma	0.012	0.12	CbGeAlD
Rifabutin—HSP90AA1—endothelium—melanoma	0.00892	0.0894	CbGeAlD
Rifabutin—HSP90AA1—hair follicle—melanoma	0.00877	0.088	CbGeAlD
Rifabutin—HSP90AA1—blood vessel—melanoma	0.00823	0.0825	CbGeAlD
Rifabutin—HSP90B1—neck—melanoma	0.00805	0.0807	CbGeAlD
Rifabutin—Uveitis—Vemurafenib—melanoma	0.00739	0.0651	CcSEcCtD
Rifabutin—HSP90B1—eye—melanoma	0.00599	0.06	CbGeAlD
Rifabutin—HSP90B1—retina—melanoma	0.00594	0.0595	CbGeAlD
Rifabutin—HSP90AA1—neck—melanoma	0.00589	0.059	CbGeAlD
Rifabutin—HSP90B1—skin of body—melanoma	0.00521	0.0522	CbGeAlD
Rifabutin—HSP90B1—mammalian vulva—melanoma	0.00475	0.0476	CbGeAlD
Rifabutin—HSP90AA1—eye—melanoma	0.00438	0.0439	CbGeAlD
Rifabutin—HSP90AA1—retina—melanoma	0.00434	0.0435	CbGeAlD
Rifabutin—HSP90AA1—skin of body—melanoma	0.00381	0.0382	CbGeAlD
Rifabutin—HSP90AA1—mammalian vulva—melanoma	0.00347	0.0348	CbGeAlD
Rifabutin—HSP90B1—head—melanoma	0.0034	0.0341	CbGeAlD
Rifabutin—Lymphopenia—Temozolomide—melanoma	0.00258	0.0227	CcSEcCtD
Rifabutin—HSP90AA1—head—melanoma	0.00249	0.0249	CbGeAlD
Rifabutin—HSP90B1—lymph node—melanoma	0.00238	0.0239	CbGeAlD
Rifabutin—Aphasia—Carmustine—melanoma	0.00211	0.0185	CcSEcCtD
Rifabutin—Aphasia—Temozolomide—melanoma	0.00203	0.0179	CcSEcCtD
Rifabutin—HSP90AA1—lymph node—melanoma	0.00174	0.0174	CbGeAlD
Rifabutin—Lymphopenia—Docetaxel—melanoma	0.00172	0.0151	CcSEcCtD
Rifabutin—Eosinophilia—Vemurafenib—melanoma	0.0016	0.0141	CcSEcCtD
Rifabutin—Hepatic enzyme increased—Temozolomide—melanoma	0.0014	0.0123	CcSEcCtD
Rifabutin—Phosphatase alkaline increased—Temozolomide—melanoma	0.00132	0.0116	CcSEcCtD
Rifabutin—Connective tissue disorder—Vemurafenib—melanoma	0.00127	0.0112	CcSEcCtD
Rifabutin—Eye disorder—Vemurafenib—melanoma	0.00121	0.0107	CcSEcCtD
Rifabutin—Dysgeusia—Vemurafenib—melanoma	0.00111	0.00973	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.0011	0.0097	CcSEcCtD
Rifabutin—Chest discomfort—Docetaxel—melanoma	0.000992	0.00873	CcSEcCtD
Rifabutin—Bronchospasm—Bleomycin—melanoma	0.000966	0.0085	CcSEcCtD
Rifabutin—Myalgia—Vemurafenib—melanoma	0.000961	0.00846	CcSEcCtD
Rifabutin—Arthralgia—Vemurafenib—melanoma	0.000961	0.00846	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000955	0.0084	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.000954	0.0084	CcSEcCtD
Rifabutin—Pancytopenia—Bleomycin—melanoma	0.000932	0.00821	CcSEcCtD
Rifabutin—Blood bilirubin increased—Docetaxel—melanoma	0.000928	0.00817	CcSEcCtD
Rifabutin—Skin disorder—Vemurafenib—melanoma	0.000895	0.00788	CcSEcCtD
Rifabutin—Phosphatase alkaline increased—Docetaxel—melanoma	0.000878	0.00773	CcSEcCtD
Rifabutin—Pancytopenia—Dactinomycin—melanoma	0.000869	0.00765	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000863	0.0076	CcSEcCtD
Rifabutin—Neutropenia—Dactinomycin—melanoma	0.000856	0.00754	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Temozolomide—melanoma	0.000845	0.00744	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000839	0.00739	CcSEcCtD
Rifabutin—Pancytopenia—Carmustine—melanoma	0.000814	0.00716	CcSEcCtD
Rifabutin—Neutropenia—Carmustine—melanoma	0.000801	0.00705	CcSEcCtD
Rifabutin—Decreased appetite—Vemurafenib—melanoma	0.000801	0.00705	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Vemurafenib—melanoma	0.000795	0.007	CcSEcCtD
Rifabutin—Pancytopenia—Temozolomide—melanoma	0.000786	0.00692	CcSEcCtD
Rifabutin—Neutropenia—Temozolomide—melanoma	0.000774	0.00682	CcSEcCtD
Rifabutin—Agranulocytosis—Dactinomycin—melanoma	0.000762	0.00671	CcSEcCtD
Rifabutin—Hepatitis—Dactinomycin—melanoma	0.000733	0.00645	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000733	0.00645	CcSEcCtD
Rifabutin—Body temperature increased—Vemurafenib—melanoma	0.000728	0.00641	CcSEcCtD
Rifabutin—Hepatobiliary disease—Temozolomide—melanoma	0.000698	0.00615	CcSEcCtD
Rifabutin—Hypersensitivity—Vemurafenib—melanoma	0.000679	0.00598	CcSEcCtD
Rifabutin—Connective tissue disorder—Carmustine—melanoma	0.000674	0.00593	CcSEcCtD
Rifabutin—Hepatitis—Temozolomide—melanoma	0.000663	0.00584	CcSEcCtD
Rifabutin—Asthenia—Vemurafenib—melanoma	0.000661	0.00582	CcSEcCtD
Rifabutin—Pruritus—Vemurafenib—melanoma	0.000652	0.00574	CcSEcCtD
Rifabutin—Connective tissue disorder—Temozolomide—melanoma	0.000651	0.00573	CcSEcCtD
Rifabutin—Eye disorder—Carmustine—melanoma	0.000641	0.00564	CcSEcCtD
Rifabutin—Anaemia—Bleomycin—melanoma	0.000632	0.00557	CcSEcCtD
Rifabutin—Diarrhoea—Vemurafenib—melanoma	0.00063	0.00555	CcSEcCtD
Rifabutin—Eye disorder—Temozolomide—melanoma	0.000619	0.00545	CcSEcCtD
Rifabutin—Leukopenia—Bleomycin—melanoma	0.000612	0.00539	CcSEcCtD
Rifabutin—Immune system disorder—Temozolomide—melanoma	0.000599	0.00527	CcSEcCtD
Rifabutin—Anaemia—Dactinomycin—melanoma	0.00059	0.00519	CcSEcCtD
Rifabutin—Vomiting—Vemurafenib—melanoma	0.000586	0.00516	CcSEcCtD
Rifabutin—Chest pain—Bleomycin—melanoma	0.000582	0.00513	CcSEcCtD
Rifabutin—Myalgia—Bleomycin—melanoma	0.000582	0.00513	CcSEcCtD
Rifabutin—Rash—Vemurafenib—melanoma	0.000581	0.00511	CcSEcCtD
Rifabutin—Dermatitis—Vemurafenib—melanoma	0.00058	0.00511	CcSEcCtD
Rifabutin—Headache—Vemurafenib—melanoma	0.000577	0.00508	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000574	0.00505	CcSEcCtD
Rifabutin—Leukopenia—Dactinomycin—melanoma	0.000571	0.00503	CcSEcCtD
Rifabutin—Dysgeusia—Temozolomide—melanoma	0.000565	0.00497	CcSEcCtD
Rifabutin—Confusional state—Bleomycin—melanoma	0.000563	0.00496	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Docetaxel—melanoma	0.000562	0.00495	CcSEcCtD
Rifabutin—Anaemia—Carmustine—melanoma	0.000552	0.00486	CcSEcCtD
Rifabutin—Nausea—Vemurafenib—melanoma	0.000547	0.00482	CcSEcCtD
Rifabutin—Thrombocytopenia—Bleomycin—melanoma	0.000547	0.00481	CcSEcCtD
Rifabutin—Myalgia—Dactinomycin—melanoma	0.000543	0.00478	CcSEcCtD
Rifabutin—Bronchospasm—Docetaxel—melanoma	0.000542	0.00477	CcSEcCtD
Rifabutin—Leukopenia—Carmustine—melanoma	0.000534	0.00471	CcSEcCtD
Rifabutin—Anaemia—Temozolomide—melanoma	0.000533	0.0047	CcSEcCtD
Rifabutin—Anorexia—Bleomycin—melanoma	0.000532	0.00468	CcSEcCtD
Rifabutin—Pancytopenia—Docetaxel—melanoma	0.000523	0.0046	CcSEcCtD
Rifabutin—Convulsion—Carmustine—melanoma	0.000517	0.00455	CcSEcCtD
Rifabutin—Leukopenia—Temozolomide—melanoma	0.000516	0.00455	CcSEcCtD
Rifabutin—Neutropenia—Docetaxel—melanoma	0.000515	0.00453	CcSEcCtD
Rifabutin—Thrombocytopenia—Dactinomycin—melanoma	0.00051	0.00449	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000509	0.00448	CcSEcCtD
Rifabutin—Chest pain—Carmustine—melanoma	0.000508	0.00448	CcSEcCtD
Rifabutin—Myalgia—Carmustine—melanoma	0.000508	0.00448	CcSEcCtD
Rifabutin—Paraesthesia—Bleomycin—melanoma	0.000501	0.00441	CcSEcCtD
Rifabutin—Convulsion—Temozolomide—melanoma	0.0005	0.0044	CcSEcCtD
Rifabutin—Dyspnoea—Bleomycin—melanoma	0.000498	0.00438	CcSEcCtD
Rifabutin—Anorexia—Dactinomycin—melanoma	0.000496	0.00437	CcSEcCtD
Rifabutin—Confusional state—Carmustine—melanoma	0.000491	0.00433	CcSEcCtD
Rifabutin—Arthralgia—Temozolomide—melanoma	0.000491	0.00432	CcSEcCtD
Rifabutin—Myalgia—Temozolomide—melanoma	0.000491	0.00432	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000488	0.00429	CcSEcCtD
Rifabutin—Decreased appetite—Bleomycin—melanoma	0.000485	0.00427	CcSEcCtD
Rifabutin—Jaundice—Docetaxel—melanoma	0.000479	0.00421	CcSEcCtD
Rifabutin—Pain—Bleomycin—melanoma	0.000477	0.0042	CcSEcCtD
Rifabutin—Thrombocytopenia—Carmustine—melanoma	0.000477	0.0042	CcSEcCtD
Rifabutin—Confusional state—Temozolomide—melanoma	0.000475	0.00418	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000474	0.00418	CcSEcCtD
Rifabutin—Anorexia—Carmustine—melanoma	0.000464	0.00409	CcSEcCtD
Rifabutin—Hepatobiliary disease—Docetaxel—melanoma	0.000464	0.00409	CcSEcCtD
Rifabutin—Thrombocytopenia—Temozolomide—melanoma	0.000461	0.00406	CcSEcCtD
Rifabutin—Feeling abnormal—Bleomycin—melanoma	0.00046	0.00405	CcSEcCtD
Rifabutin—Agranulocytosis—Docetaxel—melanoma	0.000458	0.00403	CcSEcCtD
Rifabutin—Skin disorder—Temozolomide—melanoma	0.000457	0.00403	CcSEcCtD
Rifabutin—Decreased appetite—Dactinomycin—melanoma	0.000453	0.00398	CcSEcCtD
Rifabutin—Anorexia—Temozolomide—melanoma	0.000449	0.00395	CcSEcCtD
Rifabutin—Pain—Dactinomycin—melanoma	0.000445	0.00392	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Carmustine—melanoma	0.000444	0.00391	CcSEcCtD
Rifabutin—Body temperature increased—Bleomycin—melanoma	0.000441	0.00389	CcSEcCtD
Rifabutin—Hepatitis—Docetaxel—melanoma	0.000441	0.00388	CcSEcCtD
Rifabutin—Insomnia—Carmustine—melanoma	0.000441	0.00388	CcSEcCtD
Rifabutin—Paraesthesia—Carmustine—melanoma	0.000438	0.00385	CcSEcCtD
Rifabutin—Dyspnoea—Carmustine—melanoma	0.000434	0.00382	CcSEcCtD
Rifabutin—Connective tissue disorder—Docetaxel—melanoma	0.000433	0.00381	CcSEcCtD
Rifabutin—Feeling abnormal—Dactinomycin—melanoma	0.000429	0.00378	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000429	0.00378	CcSEcCtD
Rifabutin—Insomnia—Temozolomide—melanoma	0.000426	0.00375	CcSEcCtD
Rifabutin—Gastrointestinal pain—Dactinomycin—melanoma	0.000426	0.00375	CcSEcCtD
Rifabutin—Decreased appetite—Carmustine—melanoma	0.000424	0.00373	CcSEcCtD
Rifabutin—Paraesthesia—Temozolomide—melanoma	0.000423	0.00372	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Carmustine—melanoma	0.000421	0.0037	CcSEcCtD
Rifabutin—Dyspnoea—Temozolomide—melanoma	0.00042	0.0037	CcSEcCtD
Rifabutin—Pain—Carmustine—melanoma	0.000417	0.00367	CcSEcCtD
Rifabutin—Dyspepsia—Temozolomide—melanoma	0.000415	0.00365	CcSEcCtD
Rifabutin—Eye disorder—Docetaxel—melanoma	0.000412	0.00363	CcSEcCtD
Rifabutin—Abdominal pain—Dactinomycin—melanoma	0.000412	0.00362	CcSEcCtD
Rifabutin—Body temperature increased—Dactinomycin—melanoma	0.000412	0.00362	CcSEcCtD
Rifabutin—Hypersensitivity—Bleomycin—melanoma	0.000411	0.00362	CcSEcCtD
Rifabutin—Decreased appetite—Temozolomide—melanoma	0.000409	0.0036	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Temozolomide—melanoma	0.000407	0.00358	CcSEcCtD
Rifabutin—Pain—Temozolomide—melanoma	0.000403	0.00355	CcSEcCtD
Rifabutin—Feeling abnormal—Carmustine—melanoma	0.000402	0.00354	CcSEcCtD
Rifabutin—Asthenia—Bleomycin—melanoma	0.000401	0.00353	CcSEcCtD
Rifabutin—Gastrointestinal pain—Carmustine—melanoma	0.000398	0.00351	CcSEcCtD
Rifabutin—Immune system disorder—Docetaxel—melanoma	0.000398	0.00351	CcSEcCtD
Rifabutin—Pruritus—Bleomycin—melanoma	0.000395	0.00348	CcSEcCtD
Rifabutin—Feeling abnormal—Temozolomide—melanoma	0.000388	0.00342	CcSEcCtD
Rifabutin—Abdominal pain—Carmustine—melanoma	0.000385	0.00339	CcSEcCtD
Rifabutin—Body temperature increased—Carmustine—melanoma	0.000385	0.00339	CcSEcCtD
Rifabutin—Gastrointestinal pain—Temozolomide—melanoma	0.000385	0.00339	CcSEcCtD
Rifabutin—Hypersensitivity—Dactinomycin—melanoma	0.000384	0.00338	CcSEcCtD
Rifabutin—Dysgeusia—Docetaxel—melanoma	0.000376	0.00331	CcSEcCtD
Rifabutin—Asthenia—Dactinomycin—melanoma	0.000374	0.00329	CcSEcCtD
Rifabutin—Abdominal pain—Temozolomide—melanoma	0.000372	0.00328	CcSEcCtD
Rifabutin—Body temperature increased—Temozolomide—melanoma	0.000372	0.00328	CcSEcCtD
Rifabutin—Hypersensitivity—Carmustine—melanoma	0.000359	0.00316	CcSEcCtD
Rifabutin—Diarrhoea—Dactinomycin—melanoma	0.000356	0.00314	CcSEcCtD
Rifabutin—Vomiting—Bleomycin—melanoma	0.000355	0.00312	CcSEcCtD
Rifabutin—Anaemia—Docetaxel—melanoma	0.000355	0.00312	CcSEcCtD
Rifabutin—Rash—Bleomycin—melanoma	0.000352	0.0031	CcSEcCtD
Rifabutin—Dermatitis—Bleomycin—melanoma	0.000352	0.0031	CcSEcCtD
Rifabutin—Asthenia—Carmustine—melanoma	0.00035	0.00308	CcSEcCtD
Rifabutin—Hypersensitivity—Temozolomide—melanoma	0.000347	0.00305	CcSEcCtD
Rifabutin—Leukopenia—Docetaxel—melanoma	0.000343	0.00302	CcSEcCtD
Rifabutin—Asthenia—Temozolomide—melanoma	0.000338	0.00297	CcSEcCtD
Rifabutin—Diarrhoea—Carmustine—melanoma	0.000333	0.00294	CcSEcCtD
Rifabutin—Pruritus—Temozolomide—melanoma	0.000333	0.00293	CcSEcCtD
Rifabutin—Convulsion—Docetaxel—melanoma	0.000332	0.00293	CcSEcCtD
Rifabutin—Nausea—Bleomycin—melanoma	0.000332	0.00292	CcSEcCtD
Rifabutin—Vomiting—Dactinomycin—melanoma	0.000331	0.00291	CcSEcCtD
Rifabutin—Rash—Dactinomycin—melanoma	0.000328	0.00289	CcSEcCtD
Rifabutin—Chest pain—Docetaxel—melanoma	0.000327	0.00288	CcSEcCtD
Rifabutin—Myalgia—Docetaxel—melanoma	0.000327	0.00288	CcSEcCtD
Rifabutin—Arthralgia—Docetaxel—melanoma	0.000327	0.00288	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000324	0.00286	CcSEcCtD
Rifabutin—Diarrhoea—Temozolomide—melanoma	0.000322	0.00284	CcSEcCtD
Rifabutin—Confusional state—Docetaxel—melanoma	0.000316	0.00278	CcSEcCtD
Rifabutin—Vomiting—Carmustine—melanoma	0.00031	0.00273	CcSEcCtD
Rifabutin—Nausea—Dactinomycin—melanoma	0.000309	0.00272	CcSEcCtD
Rifabutin—Shock—Docetaxel—melanoma	0.000308	0.00271	CcSEcCtD
Rifabutin—Rash—Carmustine—melanoma	0.000307	0.0027	CcSEcCtD
Rifabutin—Dermatitis—Carmustine—melanoma	0.000307	0.0027	CcSEcCtD
Rifabutin—Thrombocytopenia—Docetaxel—melanoma	0.000307	0.0027	CcSEcCtD
Rifabutin—Headache—Carmustine—melanoma	0.000305	0.00269	CcSEcCtD
Rifabutin—Skin disorder—Docetaxel—melanoma	0.000304	0.00268	CcSEcCtD
Rifabutin—Vomiting—Temozolomide—melanoma	0.000299	0.00264	CcSEcCtD
Rifabutin—Anorexia—Docetaxel—melanoma	0.000298	0.00263	CcSEcCtD
Rifabutin—Rash—Temozolomide—melanoma	0.000297	0.00261	CcSEcCtD
Rifabutin—Dermatitis—Temozolomide—melanoma	0.000297	0.00261	CcSEcCtD
Rifabutin—Headache—Temozolomide—melanoma	0.000295	0.0026	CcSEcCtD
Rifabutin—Nausea—Carmustine—melanoma	0.000289	0.00255	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000285	0.00251	CcSEcCtD
Rifabutin—Insomnia—Docetaxel—melanoma	0.000283	0.00249	CcSEcCtD
Rifabutin—Paraesthesia—Docetaxel—melanoma	0.000281	0.00248	CcSEcCtD
Rifabutin—Nausea—Temozolomide—melanoma	0.00028	0.00246	CcSEcCtD
Rifabutin—Dyspnoea—Docetaxel—melanoma	0.000279	0.00246	CcSEcCtD
Rifabutin—Dyspepsia—Docetaxel—melanoma	0.000276	0.00243	CcSEcCtD
Rifabutin—Decreased appetite—Docetaxel—melanoma	0.000272	0.0024	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Docetaxel—melanoma	0.00027	0.00238	CcSEcCtD
Rifabutin—Pain—Docetaxel—melanoma	0.000268	0.00236	CcSEcCtD
Rifabutin—Feeling abnormal—Docetaxel—melanoma	0.000258	0.00227	CcSEcCtD
Rifabutin—Gastrointestinal pain—Docetaxel—melanoma	0.000256	0.00225	CcSEcCtD
Rifabutin—Abdominal pain—Docetaxel—melanoma	0.000248	0.00218	CcSEcCtD
Rifabutin—Body temperature increased—Docetaxel—melanoma	0.000248	0.00218	CcSEcCtD
Rifabutin—Hypersensitivity—Docetaxel—melanoma	0.000231	0.00203	CcSEcCtD
Rifabutin—Asthenia—Docetaxel—melanoma	0.000225	0.00198	CcSEcCtD
Rifabutin—Pruritus—Docetaxel—melanoma	0.000222	0.00195	CcSEcCtD
Rifabutin—Diarrhoea—Docetaxel—melanoma	0.000214	0.00189	CcSEcCtD
Rifabutin—Vomiting—Docetaxel—melanoma	0.000199	0.00175	CcSEcCtD
Rifabutin—Rash—Docetaxel—melanoma	0.000197	0.00174	CcSEcCtD
Rifabutin—Dermatitis—Docetaxel—melanoma	0.000197	0.00174	CcSEcCtD
Rifabutin—Headache—Docetaxel—melanoma	0.000196	0.00173	CcSEcCtD
Rifabutin—Nausea—Docetaxel—melanoma	0.000186	0.00164	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—IL6—melanoma	3.76e-05	0.000137	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MYC—melanoma	3.7e-05	0.000134	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HRAS—melanoma	3.7e-05	0.000134	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MAPK3—melanoma	3.67e-05	0.000134	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HLA-A—melanoma	3.66e-05	0.000133	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TERT—melanoma	3.66e-05	0.000133	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—RAC1—melanoma	3.65e-05	0.000133	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—TLR4—melanoma	3.62e-05	0.000132	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-DRB1—melanoma	3.62e-05	0.000132	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MAPK1—melanoma	3.62e-05	0.000132	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ABCB1—melanoma	3.58e-05	0.00013	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SYK—melanoma	3.57e-05	0.00013	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ACER3—melanoma	3.57e-05	0.00013	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL6—melanoma	3.54e-05	0.000129	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ITGAV—melanoma	3.5e-05	0.000127	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NGFR—melanoma	3.5e-05	0.000127	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT3—melanoma	3.5e-05	0.000127	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HIF1A—melanoma	3.5e-05	0.000127	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MAPK1—melanoma	3.49e-05	0.000127	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EGFR—melanoma	3.49e-05	0.000127	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ICAM1—melanoma	3.47e-05	0.000126	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MAPK3—melanoma	3.4e-05	0.000124	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—NRAS—melanoma	3.39e-05	0.000123	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD80—melanoma	3.34e-05	0.000122	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KIT—melanoma	3.34e-05	0.000121	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TNF—melanoma	3.33e-05	0.000121	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MYC—melanoma	3.31e-05	0.00012	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGF—melanoma	3.3e-05	0.00012	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—KRAS—melanoma	3.3e-05	0.00012	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PRKCA—melanoma	3.3e-05	0.00012	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ERCC2—melanoma	3.27e-05	0.000119	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—AKT1—melanoma	3.26e-05	0.000119	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—UGT2B10—melanoma	3.26e-05	0.000119	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MAPK3—melanoma	3.24e-05	0.000118	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SOCS1—melanoma	3.24e-05	0.000118	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MAPK1—melanoma	3.23e-05	0.000118	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—S100B—melanoma	3.23e-05	0.000118	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	3.22e-05	0.000117	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOS2—melanoma	3.18e-05	0.000116	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOTCH1—melanoma	3.15e-05	0.000115	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CASP8—melanoma	3.11e-05	0.000113	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ERBB4—melanoma	3.09e-05	0.000112	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CD80—melanoma	3.09e-05	0.000112	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MAPK1—melanoma	3.09e-05	0.000112	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EGFR—melanoma	3.08e-05	0.000112	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—APC—melanoma	3.08e-05	0.000112	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KIT—melanoma	3.08e-05	0.000112	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDH1—melanoma	3.07e-05	0.000112	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN2B—melanoma	3.06e-05	0.000111	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGF—melanoma	3.05e-05	0.000111	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HS3ST5—melanoma	3.03e-05	0.00011	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CD86—melanoma	2.96e-05	0.000108	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAP2K1—melanoma	2.95e-05	0.000107	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EDN1—melanoma	2.94e-05	0.000107	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CD—melanoma	2.93e-05	0.000107	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—KRAS—melanoma	2.91e-05	0.000106	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—BRAF—melanoma	2.9e-05	0.000105	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CSF2—melanoma	2.87e-05	0.000105	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FGF1—melanoma	2.87e-05	0.000105	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—E2F1—melanoma	2.81e-05	0.000102	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—FGF2—melanoma	2.81e-05	0.000102	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—HRAS—melanoma	2.8e-05	0.000102	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PDGFRA—melanoma	2.78e-05	0.000101	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ITGB3—melanoma	2.76e-05	0.0001	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PRKCA—melanoma	2.76e-05	0.0001	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ACER3—melanoma	2.75e-05	0.0001	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAP2K1—melanoma	2.73e-05	9.92e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—melanoma	2.72e-05	9.87e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CD—melanoma	2.71e-05	9.85e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SPP1—melanoma	2.7e-05	9.83e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAP2K2—melanoma	2.69e-05	9.8e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—IL6—melanoma	2.68e-05	9.76e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CA—melanoma	2.68e-05	9.74e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—BCL2—melanoma	2.67e-05	9.7e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IFNG—melanoma	2.64e-05	9.61e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MDM2—melanoma	2.63e-05	9.56e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—FGF2—melanoma	2.59e-05	9.43e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ERBB2—melanoma	2.59e-05	9.43e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CG—melanoma	2.58e-05	9.39e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TERT—melanoma	2.56e-05	9.32e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CB—melanoma	2.56e-05	9.3e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RAC1—melanoma	2.55e-05	9.29e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD4—melanoma	2.55e-05	9.29e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—UGT2B10—melanoma	2.52e-05	9.15e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PPARG—melanoma	2.49e-05	9.06e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—HRAS—melanoma	2.48e-05	9.01e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—AKT1—melanoma	2.48e-05	9.01e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HIF1A—melanoma	2.45e-05	8.91e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.44e-05	8.87e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MDM2—melanoma	2.43e-05	8.83e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDKN1B—melanoma	2.4e-05	8.73e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ERBB2—melanoma	2.39e-05	8.7e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IL6—melanoma	2.37e-05	8.62e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CB—melanoma	2.36e-05	8.59e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CD4—melanoma	2.36e-05	8.57e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL2—melanoma	2.35e-05	8.54e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KDR—melanoma	2.34e-05	8.52e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTGS2—melanoma	2.34e-05	8.51e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HS3ST5—melanoma	2.34e-05	8.51e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLCB4—melanoma	2.3e-05	8.36e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CD—melanoma	2.27e-05	8.25e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CTNNB1—melanoma	2.27e-05	8.25e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FN1—melanoma	2.26e-05	8.2e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	2.25e-05	8.2e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ALB—melanoma	2.24e-05	8.15e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN1B—melanoma	2.22e-05	8.06e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDKN1A—melanoma	2.22e-05	8.06e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PTEN—melanoma	2.21e-05	8.04e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOTCH1—melanoma	2.21e-05	8.03e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NFKB1—melanoma	2.2e-05	8e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—AKT1—melanoma	2.19e-05	7.95e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CD80—melanoma	2.16e-05	7.86e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC6A11—melanoma	2.16e-05	7.86e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIP4K2A—melanoma	2.16e-05	7.86e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KIT—melanoma	2.16e-05	7.85e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APC—melanoma	2.16e-05	7.85e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CG—melanoma	2.16e-05	7.85e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGF—melanoma	2.13e-05	7.76e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MTAP—melanoma	2.1e-05	7.64e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CTNNB1—melanoma	2.09e-05	7.61e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.05e-05	7.47e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN1A—melanoma	2.05e-05	7.44e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTEN—melanoma	2.04e-05	7.42e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—BRAF—melanoma	2.03e-05	7.38e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CB—melanoma	1.98e-05	7.19e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—STAT3—melanoma	1.98e-05	7.19e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IGF1—melanoma	1.98e-05	7.19e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NRAS—melanoma	1.97e-05	7.17e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS2—melanoma	1.96e-05	7.13e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAP2K1—melanoma	1.91e-05	6.95e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CD—melanoma	1.9e-05	6.9e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK3—melanoma	1.89e-05	6.87e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PHGDH—melanoma	1.87e-05	6.81e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LUM—melanoma	1.87e-05	6.81e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HPSE—melanoma	1.84e-05	6.68e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—STAT3—melanoma	1.83e-05	6.64e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NRAS—melanoma	1.82e-05	6.62e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FGF2—melanoma	1.82e-05	6.61e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CUBN—melanoma	1.8e-05	6.56e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK1—melanoma	1.8e-05	6.54e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGFR—melanoma	1.8e-05	6.53e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLCB4—melanoma	1.77e-05	6.45e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAPK3—melanoma	1.74e-05	6.34e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SDHD—melanoma	1.74e-05	6.33e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CSPG4—melanoma	1.74e-05	6.33e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—BSG—melanoma	1.74e-05	6.33e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTEN—melanoma	1.71e-05	6.22e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MDM2—melanoma	1.7e-05	6.18e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KRAS—melanoma	1.7e-05	6.17e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MYC—melanoma	1.7e-05	6.17e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPAM—melanoma	1.69e-05	6.13e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ERBB2—melanoma	1.68e-05	6.09e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC6A11—melanoma	1.67e-05	6.06e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIP4K2A—melanoma	1.67e-05	6.06e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAPK1—melanoma	1.66e-05	6.03e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGFR—melanoma	1.66e-05	6.03e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CB—melanoma	1.65e-05	6.01e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MTAP—melanoma	1.62e-05	5.9e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL8—melanoma	1.59e-05	5.78e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KRAS—melanoma	1.57e-05	5.7e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CA—melanoma	1.56e-05	5.67e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN1B—melanoma	1.55e-05	5.64e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CASP3—melanoma	1.52e-05	5.53e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL2—melanoma	1.52e-05	5.52e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCND1—melanoma	1.48e-05	5.38e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CTNNB1—melanoma	1.47e-05	5.33e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LUM—melanoma	1.45e-05	5.26e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PHGDH—melanoma	1.45e-05	5.26e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HRAS—melanoma	1.44e-05	5.25e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CA—melanoma	1.44e-05	5.24e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP9—melanoma	1.44e-05	5.23e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLA2G6—melanoma	1.43e-05	5.21e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN1A—melanoma	1.43e-05	5.21e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTEN—melanoma	1.43e-05	5.2e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NFKB1—melanoma	1.42e-05	5.17e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HPSE—melanoma	1.42e-05	5.15e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CUBN—melanoma	1.39e-05	5.06e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6—melanoma	1.38e-05	5.02e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SDHD—melanoma	1.34e-05	4.89e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—BSG—melanoma	1.34e-05	4.89e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CSPG4—melanoma	1.34e-05	4.89e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HRAS—melanoma	1.33e-05	4.84e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPAM—melanoma	1.3e-05	4.73e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—melanoma	1.29e-05	4.69e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—VCAN—melanoma	1.29e-05	4.68e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—STAT3—melanoma	1.28e-05	4.65e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NRAS—melanoma	1.28e-05	4.64e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6—melanoma	1.27e-05	4.64e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—AKT1—melanoma	1.27e-05	4.63e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK3—melanoma	1.22e-05	4.44e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.22e-05	4.43e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CA—melanoma	1.21e-05	4.38e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MYC—melanoma	1.19e-05	4.32e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.18e-05	4.28e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—AKT1—melanoma	1.18e-05	4.28e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK1—melanoma	1.16e-05	4.23e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGFR—melanoma	1.16e-05	4.22e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLA2G6—melanoma	1.11e-05	4.02e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KRAS—melanoma	1.1e-05	3.99e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP17A1—melanoma	1.09e-05	3.95e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.07e-05	3.9e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.06e-05	3.85e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GNA11—melanoma	1.03e-05	3.73e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CA—melanoma	1.01e-05	3.67e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—FASN—melanoma	1e-05	3.65e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—VCAN—melanoma	9.94e-06	3.61e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC5A5—melanoma	9.88e-06	3.59e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AKT1—melanoma	9.85e-06	3.58e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—melanoma	9.75e-06	3.55e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GNAQ—melanoma	9.54e-06	3.47e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CD44—melanoma	9.54e-06	3.47e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.34e-06	3.4e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HRAS—melanoma	9.33e-06	3.39e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.26e-06	3.37e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP1B1—melanoma	9.15e-06	3.33e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6—melanoma	8.93e-06	3.25e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP17A1—melanoma	8.39e-06	3.05e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT1—melanoma	8.24e-06	3e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.07e-06	2.94e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GNA11—melanoma	7.92e-06	2.88e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—FASN—melanoma	7.75e-06	2.82e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC5A5—melanoma	7.62e-06	2.77e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCB1—melanoma	7.53e-06	2.74e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GNAQ—melanoma	7.36e-06	2.68e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CD44—melanoma	7.36e-06	2.68e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP1B1—melanoma	7.06e-06	2.57e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PRKCA—melanoma	6.93e-06	2.52e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ERCC2—melanoma	6.87e-06	2.5e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCB1—melanoma	5.81e-06	2.11e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.69e-06	2.07e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CG—melanoma	5.43e-06	1.97e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PRKCA—melanoma	5.35e-06	1.95e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ERCC2—melanoma	5.31e-06	1.93e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPARG—melanoma	5.24e-06	1.91e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CD—melanoma	4.77e-06	1.74e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALB—melanoma	4.71e-06	1.71e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CG—melanoma	4.19e-06	1.52e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CB—melanoma	4.16e-06	1.51e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS2—melanoma	4.12e-06	1.5e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPARG—melanoma	4.04e-06	1.47e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CD—melanoma	3.68e-06	1.34e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALB—melanoma	3.64e-06	1.32e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTEN—melanoma	3.6e-06	1.31e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CB—melanoma	3.21e-06	1.17e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS2—melanoma	3.18e-06	1.16e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTEN—melanoma	2.77e-06	1.01e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CA—melanoma	2.54e-06	9.22e-06	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKT1—melanoma	2.07e-06	7.53e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CA—melanoma	1.96e-06	7.12e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKT1—melanoma	1.6e-06	5.81e-06	CbGpPWpGaD
